Answers are grounded in this paper and cite their sources.
In campaign 1, 103.9 kg of (S)-2-(N-benzyl-N-methylamino)-1-propanamine d-tartaric acid salt (4) was prepared in 3 stages from l-alaninamide·HCl. The Stage 2 reaction, the reductive amination of (S)-2-benzylaminopropionamide (2) with aqueous formalin using H2, Pd/C, and THF as solvent, proved to be nonrobust. Ahead of campaign 2, the Stage 2 and 3 processes were redeveloped to provide a higher yielding and more robust set of reaction conditions. The key change was to conduct the reductive amination of (S)-2-benzylaminopropionamide (2) with aqueous formalin using NaBH4 in MeOH as solvent while maintaining a constant pH (pH = 8.5) by the addition of acetic acid. In campaign 2, (S)-2-(N-benzyl-N-methylamino)-1-propanamine was isolated as the d-mandelic acid salt. A total of 373 kg of (S)-2-(N-benzyl-N-methylamino)-1-propanamine d-mandelic acid salt was produced in high yield and excellent quality. (S)-2-(N-Benzyl-N-methylamino)-1-propanamine is a key intermediate in the synthesis of the orexin 1 receptor antagonist C4X3256.
No takes yet. Share an insight, caveat, or question.
Carey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: